Triptodur 22.5 MG Injection
- RxCUI
- 1944389
- RxNorm name
- Triptodur 22.5 MG Injection
- Display name
- Triptodur 22.5 MG Injection
- Full name
- Triptodur 22.5 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TRIPTODUR | TRIPTORELIN | Azurity Pharmaceuticals, Inc. | f41380e7-b830-432d-a5f5-a872932f107e | 2025-09-14 | Warnings, Adverse reactions | 1944389 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f41380e7-b830-432d-a5f5-a872932f107e | Triptodur 22.5 MG Injection | PSN | 16 | These highlights do not include all the information needed to use TRIPTODUR ® safely and effectively. See full prescribing information for TRIPTODUR. TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2000 | 20250914 |
| f41380e7-b830-432d-a5f5-a872932f107e | triptorelin 22.5 MG Injection [Triptodur] | SBD | 16 | These highlights do not include all the information needed to use TRIPTODUR ® safely and effectively. See full prescribing information for TRIPTODUR. TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2000 | 20250914 |
| f41380e7-b830-432d-a5f5-a872932f107e | Triptodur 22.5 MG Injection | SY | 16 | These highlights do not include all the information needed to use TRIPTODUR ® safely and effectively. See full prescribing information for TRIPTODUR. TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2000 | 20250914 |